NEW YORK (GenomeWeb News) – Stocks in the GenomeWeb Daily News Index continued their rebound for the second straight month, with Affymetrix rising sharply for the second time in as many months. Meanwhile, Sequenom's shares tumbled on the last day of the month after the firm announced that it would delay the launch of its SEQureDx Down syndrome test due to company employees mishandling R&D test data and results.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.